Gunderson Dettmer represented client Syapse, a leading real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health Network^TM, in its $68 million growth equity investment led by Ally Bridge Group and Northpoint Ventures. The new funding will be used to expand Syapse’s focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer. 

In the announcement of the transaction, CEO of Syapse Ken Tarkoff said, “We are extremely pleased that Ally Bridge Group and Northpond Ventures embrace our vision of providing high-quality healthcare to cancer patients, and building a global network that integrates a great deal of provider-driven data to deliver actionable insights to health systems and their patients.”

The Gunderson deal team was led by Dan O’Connor and included  Michael Richman, Stephanie Lane, Jesse Birbach and Hannah Porter.